Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth

Figure 1 Comparative analysis of tuftelin 1 messenger RNA between hepatocellular carcinoma and normal livers based on bioinformatics databases. A: The expression of tuftelin 1 (TUFT1) messenger RNA in the cancerous tissues of hepatocellular carcinoma (HCC) patients (n = 369, red, ^aP < 0.05) and normal liver tissues (n = 50, grey) from the Cancer Genome Atlas database; B: The expression of TUFT1 messenger RNA in the cancerous tissues of HCC patients (n = 225, dark blue, ^aP < 0.05) and normal liver tissues (n = 220, light blue) from the Oncomine database. The horizontal line represents the median of the two groups. Vertical bars indicate the range of data. LIHC: Liver hepatocellular carcinoma.